Delisting Determination,The Nasdaq Stock Market, LLC,
January 26, 2016, KaloBios Pharmaceuticals, Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of KaloBios Pharmaceuticals, Inc.
(the Company), effective at the opening of the trading
session on February 5, 2016. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rules 5100, 5110(b), 5250(c)(1) and
5605(c)(2). The Company was notified of the Staffs
determination on December 18, 2015.  The Company appealed
the determination to a Hearing Panel. On january 12,
2016, the Company withdrew its request for an appeal.
The Staff determination to delist the Company
became final on January 13, 2016.